SCRUM ALLIANCE® AND SCRUM INC. ANNOUNCE PARTNERSHIP ON SCRUM@SCALE® FRAMEWORK FOR ORGANIZATIONAL AGILE TRANSFORMATION
Scrum Alliance launches joint venture with Dr. Jeff Sutherland's Scrum@Scale LLC.
DENVER, CO, and CAMBRIDGE, MA, April 16, 2018 (GLOBE NEWSWIRE) -- Scrum Alliance® and Scrum Inc. are launching a new joint venture to train, coach, and promote Dr. Jeff Sutherland's framework for Agile transformation via scaling Scrum across entire organizations.
Scrum Alliance is the largest and most established Scrum certifying body and professional association of Agile practitioners in the world. With more than 500,000 certified practitioners, Scrum Alliance is dedicated to helping individuals and organizations transform their world of work. Scrum Inc. founded by Dr. Jeff Sutherlrand the co-creator of Scrum is the world's leading authority of implementing Scrum. They have helped hundreds of organizations, from Fortune 100 companies to start-ups, fundamentally reshape themselves to dramatically increase productivity and drive growth.
Scrum@Scale ® is the natural extension of the Scrum framework. It is designed to deliver business agility across an entire organization: all departments, products, and services. No matter the industry, Scrum@Scale makes every team a Scrum team and transforms organizations into market-disrupting forces. Dr. Sutherland, one of the original signers of the Agile Manifesto, recently stepped down from his position as CEO of Scrum Inc. to focus on the training and implementation of Scrum@Scale.
"Scrum@Scale is a framework where networks of Scrum teams can efficiently address complex problems while creatively delivering products of the highest possible value," said Sutherland. "We look forward to working with Scrum Alliance and their tremendous networks of trainers, coaches, and members to promote this new way of building healthy, high-functioning organizations."
"We believe Scrum@Scale offers organizations a strong solution for a Scrum scaling framework," said Scrum Alliance Board Member Lisa Hershman. "We are so excited to offer our community of trainers and coaches access to the Scrum@Scale education tools and framework solutions for a new phase in our mission of transforming the world of work."
As the world becomes more Agile, more businesses search for ways to incorporate scaling solutions in their organizations. Scrum Alliance and Scrum Inc. share a vision to help as many organizations as possible practice "good Scrum" and change the world of work. Scrum@Scale achieves this goal through setting up a "minimum viable bureaucracy" that extends the benefits of single Scrum team across the organization.
The partnership was announced at the Scrum Alliance 2018 North American Global Scrum Gathering® in Minneapolis. The sold-out event was the largest Global Scrum Gathering in Scrum Alliance history.
To learn more about Scrum@Scale, read the open source Scrum@Scale Guide, which is being translated into dozens of additional languages.
About Scrum Alliance
Founded in 2001, Scrum Alliance® is the largest, most established and influential professional membership and certification organization in the Agile community. Scrum Alliance is a nonprofit association with more than 500,000 certified practitioners worldwide. Its vision is to help "Transform the World of Work" with a mission to guide and inspire individuals, leaders, and organizations with practices, principles, and values that create workplaces that are joyful, prosperous, and sustainable. For more information, please visit scrumalliance.org.
Connect with us on social media at:
About Scrum Inc.
Scrum Inc., the world's leading authority on Scrum, provides training, consulting, and coaching that enables organizations to deliver value faster and reduce waste. Scrum Inc. was founded by Dr. Jeff Sutherland, the co-creator of Scrum, and has helped hundreds of organizations, from Fortune 100 companies to start-ups, fundamentally reshape themselves to dramatically increase productivity and drive growth. Scrum Inc. is the preeminent thought leader in the Agile community and publishes scientific papers, case studies, blogs, online educational content, and management and leadership books such as our recent best-selling Scrum: The Art of Doing Twice the Work in Half the Time.
About Scrum@Scale LLC
Scrum@Scale is a training and certification company that provides Scrum Practitioners with the most current learning thy need to Scale Scrum, to teach others the Scrum@Scale framework, and to address complex problems using the framework, while delivering high-value products and services. We do this by delivering rigorous training, openly sharing knowledge, and being the go-to thought leader regarding organizational transformation. Learn more at scrumatscale.com.
Heather Leigh Scrum Alliance. 720-443-7314 firstname.lastname@example.org Veronica Ruiz Scrum Inc. Public Relations 718-781-4168 email@example.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Scrum Alliance via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-10125.9.2018 14:00 | Pressemelding
Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC patients targeted to commence in 2019 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer in Toronto. The oral presentation included further details on, and updates from, the dataset announced previously. CK-101 is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being evaluated in advanced non
SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test25.9.2018 14:00 | Pressemelding
Test supports international guidelines for treating antibiotic resistant STI SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not available for sale in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen or MG, along with genetic markers linked to antibiotic resistance. In recent years, Mgen prevalence has increased globally and developed high rates of resistance to the common antibiotic treatment, azithromycin. "This test is an exciting new development that will increase the precision of patient care for patients impacted by Mycoplasma genitalium - a common sexually transmitted infection with limited treatment options,” notes Dr Maria Trent, Professor of Pediatrics and Public Health at Johns Hopkins Medicine. The SpeeDx ResistancePlus MG test is in use in laboratories acr
Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults25.9.2018 13:00 | Pressemelding
First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration (FDA) and Phase 3 clinical trial design GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older adults of NanoFlu, its nanoparticle seasonal influenza vaccine candidate. “Initiating this Phase 2 clinical trial of NanoFlu is an important milestone for Novavax,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “With top-line results expected in the first quarter of 2019, we plan to discuss these data with the FDA at an ‘End of Phase 2’ meeting and to agree on the appropriate Phase 3 clinical trial design to support licensure via accelerated approval. We continue to believe NanoFlu is a differen
CGAP Launches Photo and Video Contest Theme for 2018: Financial Inclusion in Africa25.9.2018 13:00 | Pressemelding
This year's CGAP contest is the first ever to accept short video entries WASHINGTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The Consultative Group to Assist the Poor’s (CGAP) 13th annual photo contest, launched today, is seeking striking images on financial inclusion in Africa. For the first time, short video submissions on Africa also will be accepted. Entries may be submitted through December 14, 2018. Each contestant may submit up to 20 photos or videos to compete for the Grand Prize worth US$ 2,000. This year CGAP is looking for original and compelling photographs and short videos that tell the story of how financial services empower poor people and communities in Africa. The region is a center for financial innovation -- home to M-Pesa, the mobile money service launched a decade ago now replicated across markets worldwide; host to vibrant FinTech and e-commerce companies; and to a growing off-grid sector that leverages digital finance. Together these innovators contribute toward lifti
Kick-starting health in the workplace25.9.2018 10:00 | Pressemelding
Over 800 organizations step, bike, swim and yoga their way to better health and wellbeing as the May 2018 Virgin Pulse Global Challenge Concludes ZURICH, Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- On August 30th more than 270,000 people, across 144 countries, completed Virgin Pulse’s 100-day Global Challenge, moving them towards a more active, healthy and productive lifestyle. With this achievement, Virgin Pulse, an international leader in employee health and wellbeing, once again proves it’s helping to improve employee lives for good. The company’s Global Challenge event encourages exercise, mindfulness and healthy habits at work, leading to a happier culture and reduced costs to the organization. “Through increased awareness, education and motivation, employees master long-term, sustainable habits allowing them to arrive at work feeling more engaged, productive and equipped for peak performance,” says David Osborne, Chief Executive Officer of Virgin Pulse. “The follow-on effects
GridGain Unveils Keynote Schedule for Fourth Annual In-Memory Computing Summit North America25.9.2018 09:00 | Pressemelding
Oracle Becomes Platinum Conference Sponsor FOSTER CITY, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced the keynote speaker schedule for the fourth annual In-Memory Computing Summit® North America, taking place October 2-3, 2018 at the Hyatt Regency San Francisco Airport. Industry luminaries from ING Belgium, Wellington Management, Oracle, SNIA and GridGain Systems will discuss the evolution of in-memory computing technology and how organizations are leveraging in-memory computing to obtain the speed and scalability necessary for their digital transformation, omnichannel customer experience, Big Data and Fast Data initiatives. GridGain today also announced that Oracle has become a Platinum conference sponsor. The In-Memory Computing Summit North America 2018 is the only in-memory computing conference focusing on the full range of in-memory computing-related technologies an
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom